Home » Authors » Mark Lawson

Articles by Mark Lawson

Amrad To Stop Development Of Hepatitis B Compound

July 17, 2002

Amrad To Stop Development Of Hepatitis B Compound

July 17, 2002

Shareholders Maneuver Shakeup On Amrad's Board Before Meeting

May 29, 2002

Shareholders Maneuver Shakeup On Amrad's Board Before Meeting

May 29, 2002

Australian States Compete In Separate Biotech Initiatives

May 22, 2002

Australian States Compete In Separate Biotech Initiatives

May 22, 2002

Prima Biomed Plans Phase I/II Following Successful Phase I

May 15, 2002

Prima Biomed Plans Phase I/II Following Successful Phase I

May 15, 2002

Prana Releases Positive News In Phase II of Alzheimer’s Drug

April 17, 2002

Two Peptech Directors, Chairman Resign After Only Three Months

April 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...